184 related articles for article (PubMed ID: 37062836)
1. KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties.
Cioclu MC; Mosca I; Ambrosino P; Puzo D; Bayat A; Wortmann SB; Koch J; Strehlow V; Shirai K; Matsumoto N; Sanders SJ; Michaud V; Legendre M; Riva A; Striano P; Muhle H; Pendziwiat M; Lesca G; Mangano GD; Nardello R; ; Lemke JR; Møller RS; Soldovieri MV; Rubboli G; Taglialatela M
Ann Neurol; 2023 Aug; 94(2):332-349. PubMed ID: 37062836
[TBL] [Abstract][Full Text] [Related]
2. Recurrent KCNT2 missense variants affecting p.Arg190 result in a recognizable phenotype.
Jackson A; Banka S; Stewart H; ; Robinson H; Lovell S; Clayton-Smith J
Am J Med Genet A; 2021 Oct; 185(10):3083-3091. PubMed ID: 34061450
[TBL] [Abstract][Full Text] [Related]
3. Human
Wei AD; Wakenight P; Zwingman TA; Bard AM; Sahai N; Willemsen MH; Schelhaas HJ; Stegmann APA; Verhoeven JS; de Man SA; Wessels MW; Kleefstra T; Shinde DN; Helbig KL; Basinger A; Wagner VF; Rodriguez-Buritica D; Bryant E; Millichap JJ; Millen KJ; Dobyns WB; Ramirez JM; Kalume FK
J Neurophysiol; 2022 Jul; 128(1):40-61. PubMed ID: 35583973
[TBL] [Abstract][Full Text] [Related]
4. Case Report: Causative
Gong P; Jiao X; Yu D; Yang Z
Front Genet; 2021; 12():649556. PubMed ID: 34276763
[No Abstract] [Full Text] [Related]
5. De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy.
Ambrosino P; Soldovieri MV; Bast T; Turnpenny PD; Uhrig S; Biskup S; Döcker M; Fleck T; Mosca I; Manocchio L; Iraci N; Taglialatela M; Lemke JR
Ann Neurol; 2018 Jun; 83(6):1198-1204. PubMed ID: 29740868
[TBL] [Abstract][Full Text] [Related]
6. Additional observation of a de novo pathogenic variant in KCNT2 leading to epileptic encephalopathy with clinical features of frontal lobe epilepsy.
Inuzuka LM; Macedo-Souza LI; Della-Ripa B; Monteiro FP; Ramos L; Kitajima JP; Garzon E; Kok F
Brain Dev; 2020 Oct; 42(9):691-695. PubMed ID: 32773162
[TBL] [Abstract][Full Text] [Related]
7. De novo variants in KCNA3 cause developmental and epileptic encephalopathy.
Soldovieri MV; Ambrosino P; Mosca I; Servettini I; Pietrunti F; Belperio G; ; Syrbe S; Taglialatela M; Lemke JR
Ann Neurol; 2024 Feb; 95(2):365-376. PubMed ID: 37964487
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel
Cui F; Wulan T; Zhang Q; Zhang VW; Jiang Y
Front Genet; 2024; 15():1371282. PubMed ID: 38510274
[No Abstract] [Full Text] [Related]
9. Distinguishing Loss-of-Function and Gain-of-Function
Hack JB; Horning K; Juroske Short DM; Schreiber JM; Watkins JC; Hammer MF
Neurol Genet; 2023 Jun; 9(3):e200060. PubMed ID: 37152443
[TBL] [Abstract][Full Text] [Related]
10. Lhermitte-Duclos disease with concomitant KCNT2 gene mutation: report of an extremely rare combination.
Assi J; Chyta M; Mavridis I
Childs Nerv Syst; 2023 Nov; 39(11):3295-3299. PubMed ID: 37368068
[TBL] [Abstract][Full Text] [Related]
11. Further corroboration of distinct functional features in SCN2A variants causing intellectual disability or epileptic phenotypes.
Begemann A; Acuña MA; Zweier M; Vincent M; Steindl K; Bachmann-Gagescu R; Hackenberg A; Abela L; Plecko B; Kroell-Seger J; Baumer A; Yamakawa K; Inoue Y; Asadollahi R; Sticht H; Zeilhofer HU; Rauch A
Mol Med; 2019 Feb; 25(1):6. PubMed ID: 30813884
[TBL] [Abstract][Full Text] [Related]
12. The genotype-phenotype correlations of the
Kessi M; Chen B; Pang N; Yang L; Peng J; He F; Yin F
Front Mol Neurosci; 2023; 16():1222321. PubMed ID: 37555011
[TBL] [Abstract][Full Text] [Related]
13.
Zhang L; Wen Y; Zhang Q; Chen Y; Wang J; Shi K; Du L; Bao X
Front Pediatr; 2020; 8():577544. PubMed ID: 33425808
[No Abstract] [Full Text] [Related]
14. GABRA1-Related Disorders: From Genetic to Functional Pathways.
Musto E; Liao VWY; Johannesen KM; Fenger CD; Lederer D; Kothur K; Fisk K; Bennetts B; Vrielynck P; Delaby D; Ceulemans B; Weckhuysen S; Sparber P; Bouman A; Ardern-Holmes S; Troedson C; Battaglia DI; Goel H; Feyma T; Bakhtiari S; Tjoa L; Boxill M; Demina N; Shchagina O; Dadali E; Kruer M; Cantalupo G; Contaldo I; Polster T; Isidor B; Bova SM; Fazeli W; Wouters L; Miranda MJ; Darra F; Pede E; Le Duc D; Jamra RA; Küry S; Proietti J; McSweeney N; Brokamp E; Andrews PI; Gouray Garcia M; Chebib M; Møller RS; Ahring PK; Gardella E
Ann Neurol; 2023 Aug; ():. PubMed ID: 37606373
[TBL] [Abstract][Full Text] [Related]
15. Genotype-phenotype correlations of STXBP1 pathogenic variants and the treatment choices for STXBP1-related disorders in China.
Kessi M; Chen B; Shan LD; Wang Y; Yang L; Yin F; He F; Peng J; Wang G
BMC Med Genomics; 2023 Mar; 16(1):46. PubMed ID: 36882827
[TBL] [Abstract][Full Text] [Related]
16. De novo loss-of-function KCNMA1 variants are associated with a new multiple malformation syndrome and a broad spectrum of developmental and neurological phenotypes.
Liang L; Li X; Moutton S; Schrier Vergano SA; Cogné B; Saint-Martin A; Hurst ACE; Hu Y; Bodamer O; Thevenon J; Hung CY; Isidor B; Gerard B; Rega A; Nambot S; Lehalle D; Duffourd Y; Thauvin-Robinet C; Faivre L; Bézieau S; Dure LS; Helbling DC; Bick D; Xu C; Chen Q; Mancini GMS; Vitobello A; Wang QK
Hum Mol Genet; 2019 Sep; 28(17):2937-2951. PubMed ID: 31152168
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiological features: The next precise step for SCN2A developmental epileptic encephalopathy.
Miao P; Tang S; Ye J; Wang J; Lou Y; Zhang B; Xu X; Chen X; Li Y; Feng J
Mol Genet Genomic Med; 2020 Jul; 8(7):e1250. PubMed ID: 32400968
[TBL] [Abstract][Full Text] [Related]
18. The molecular and phenotypic spectrum of CLCN4-related epilepsy.
He H; Guzman RE; Cao D; Sierra-Marquez J; Yin F; Fahlke C; Peng J; Stauber T
Epilepsia; 2021 Jun; 62(6):1401-1415. PubMed ID: 33951195
[TBL] [Abstract][Full Text] [Related]
19. Variant-specific in vitro neuronal network phenotypes and drug sensitivity in SCN2A developmental and epileptic encephalopathy.
Jia L; Li M; Pachernegg S; Sedo A; Jancovski N; Burbano LE; Dalby K; Nemiroff A; Reid C; Maljevic S; Petrou S
J Neurochem; 2024 Mar; ():. PubMed ID: 38544375
[TBL] [Abstract][Full Text] [Related]
20. A De Novo Mutation in the Sodium-Activated Potassium Channel KCNT2 Alters Ion Selectivity and Causes Epileptic Encephalopathy.
Gururaj S; Palmer EE; Sheehan GD; Kandula T; Macintosh R; Ying K; Morris P; Tao J; Dias KR; Zhu Y; Dinger ME; Cowley MJ; Kirk EP; Roscioli T; Sachdev R; Duffey ME; Bye A; Bhattacharjee A
Cell Rep; 2017 Oct; 21(4):926-933. PubMed ID: 29069600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
